Ardsley Advisory Partners’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-19,900
Closed -$1.84M 194
2019
Q2
$1.84M Sell
19,900
-264,600
-93% -$25.1M 0.29% 53
2019
Q1
$26.8M Buy
284,500
+129,500
+84% +$11.3M 5.15% 3
2018
Q4
$9.93M Buy
155,000
+146,000
+1,622% +$10.8M 2.5% 15
2018
Q3
$805K Buy
9,000
+3,500
+64% +$309K 0.11% 76
2018
Q2
$437K Sell
5,500
-219,000
-98% -$18.2M 0.07% 118
2018
Q1
$20M Buy
+224,500
New +$21.6M 3% 6
2017
Q4
Sell
-10,000
Closed -$1.46M 187
2017
Q3
$1.46M Sell
10,000
-126,000
-93% -$17.2M 0.19% 72
2017
Q2
$17.7M Buy
136,000
+28,000
+26% +$3.43M 2.75% 7
2017
Q1
$13.4M Buy
108,000
+103,500
+2,300% +$12.4M 2.09% 12
2016
Q4
$521K Sell
4,500
-70,500
-94% -$7.85M 0.09% 85
2016
Q3
$7.84M Sell
75,000
-10,500
-12% -$1.14M 1.24% 29
2016
Q2
$8.42M Sell
85,500
-300
-0.3% -$31K 1.46% 25
2016
Q1
$8.59M Sell
85,800
-71,700
-46% -$7.38M 1.33% 22
2015
Q4
$18.9M Buy
+157,500
New +$18.2M 2.46% 8
2015
Q3
Sell
-152,000
Closed -$17.8M 226
2015
Q2
$17.8M Buy
152,000
+23,500
+18% +$2.69M 2.24% 10
2015
Q1
$14.8M Buy
128,500
+125,500
+4,183% +$15M 2.06% 13
2014
Q4
$336K Sell
3,000
-3,000
-50% -$316K 0.05% 145
2014
Q3
$569K Hold
6,000
0.08% 110
2014
Q2
$515K Buy
+6,000
New +$456K 0.07% 152
2014
Q1
Sell
-9,000
Closed -$760K 305
2013
Q4
$760K Buy
+9,000
New +$712K 0.1% 78
2013
Q3
Sell
-10,000
Closed -$585K 205
2013
Q2
$585K Buy
+10,000
New +$602K 0.13% 77

Other funds holding CELG

Ardsley Advisory Partners's CELG Position: Q3 2019 in Review

Ardsley Advisory Partners sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 19,900 shares — an estimated $1.84M sold.

Ardsley Advisory Partners first reported a position in CELG in Q2 2013 and held it in 21 quarters. The position peaked at $26.8M in Q1 2019. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Ardsley Advisory Partners reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • Ardsley Advisory Partners sold 19,900 Celgene Corp shares in Q3 2019, an estimated $1.84M.
  • Ardsley Advisory Partners first reported a position in Celgene Corp in Q2 2013 and held it in 21 quarters.
  • Ardsley Advisory Partners's Celgene Corp position peaked at $26.8M in Q1 2019.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Ardsley Advisory Partners's 13F filing for Q3 2019, filed 14 Nov 2019.